68 -- Pathatrix Bio-Threat Trial Kit

The Food and Drug Administration plans to award a sole source purchase order to Matrix MicroScience, Inc., located in Golden, Colorado, for their unique PATHATRIX system. This patented method selectively enriches specific microorganisms and is the only validated system of its kind recognized by an international validation organization for microorganisms relevant to the FDA. The purchase will include PATHATRIX Units that perform same-day tests for E.coli O157, along with the necessary antibody coatings. The action is authorized under 41 USC 253(c)(1) and is intended to occur within fifteen days following the notice date. This acquisition will be conducted in accordance with the Federal Acquisition Regulation (FAR) Parts 12 and 13, which cover commercial items and simplified acquisition procedures. While this announcement is not a request for quotes, other sources may submit descriptive materials demonstrating their capabilities for consideration. The contract is identified under the solicitation number 1005286-1005698 and relates to the procurement of bio-threat trial kits under the NAICS code 339999. No set-aside or preference status is indicated, and details on the place of performance and point of contact were not specified.